Stage II Renal Cell Cancer AJCC v7

specific

Stage III includes: (T1 or T2, N1, M0); (T3, N0 or N1, M0). T1: Lesions have been divided into T1a and T1b. T1a is defined as tumor 4 cm or less in greatest dimension, limited to the kidney. T1b is defined as tumor greater than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney. T2: Lesions have been divided into T2a and T2b. T2a is defined as tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney. T2b is defined as tumor grea

78

Centers

63

Active Trials

Cancer Funding

Top Centers for Stage II Renal Cell Cancer AJCC v7(78)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
55.0
2
NCI Comprehensive
Active Research Program
55.0
3
NCI Comprehensive
Active Research Program
55.0
4
NCI Comprehensive
Active Research Program
55.0
5
NCI Comprehensive
Active Research Program
55.0
6
NCI Comprehensive
Active Research Program
55.0
7
NCI Comprehensive
Active Research Program
55.0
8
NCI Comprehensive
Active Research Program
55.0
9
NCI Comprehensive
Active Research Program
55.0
10
NCI Comprehensive
Active Research Program
55.0
11
NCI Comprehensive
Active Research Program
55.0
12
NCI Comprehensive
Active Research Program
55.0
13
NCI Comprehensive
Active Research Program
55.0
14
NCI Comprehensive
Active Research Program
55.0
15
NCI Comprehensive
Active Research Program
55.0
16
NCI Comprehensive
Active Research Program
55.0
17
NCI Comprehensive
Active Research Program
55.0
18
NCI Comprehensive
Active Research Program
55.0
19
NCI Comprehensive
Active Research Program
55.0
20
NCI Comprehensive
Active Research Program
55.0
2155.0
22
NCI Comprehensive
Active Research Program
55.0
23
NCI Comprehensive
Active Research Program
55.0
24
NCI Comprehensive
Active Research Program
55.0
25
NCI Comprehensive
Active Research Program
55.0
26
NCI Comprehensive
Active Research Program
55.0
27
NCI Comprehensive
Active Research Program
55.0
28
NCI Clinical
Active Research Program
55.0
29
NCI Comprehensive
Active Research Program
55.0
30
NCI Comprehensive
Active Research Program
55.0
31
NCI Comprehensive
Active Research Program
55.0
32
NCI Comprehensive
Active Research Program
55.0
33
NCI Clinical
Active Research Program
55.0
34
NCI Comprehensive
Active Research Program
55.0
35
Active Research Program
55.0
36
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
55.0
37
NCI Comprehensive
Active Research Program
55.0
38
Active Research Program
55.0
39
Active Research Program
55.0
40
NCI Comprehensive
Active Research Program
55.0
41
NCI Clinical
Active Research Program
55.0
42
NCI Comprehensive
Active Research Program
55.0
43
NCI Comprehensive
Active Research Program
55.0
44
NCI Comprehensive
Active Research Program
55.0
45
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
55.0
46
Active Research Program
55.0
47
NCI Clinical
Active Research Program
55.0
48
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
55.0
49
Active Research Program
55.0
50
NCI Comprehensive
Active Research Program
55.0
5155.0
52
Active Research Program
55.0
53
Active Research Program
55.0
54
Active Research Program
55.0
55
Active Research Program
55.0
56
Active Research Program
55.0
57
Active Research Program
55.0
58
Active Research Program
55.0
59
Active Research Program
55.0
60
Active Research Program
55.0
61
Active Research Program
55.0
62
Active Research Program
55.0
63
Active Research Program
55.0
64
NCI Comprehensive
32.5
65
NCI Comprehensive
32.5
66
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
32.5
6732.5
68
NCI Comprehensive
32.5
69
NCI Comprehensive
32.5
70
NCI Comprehensive
32.5
7132.5
7232.5
7332.5
7432.5
7532.5
76
BC CancerVancouver, BC
32.5
7732.5
7832.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →